| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/10/2011 | US20110033559 Dietary Calcium for Reducing the Production of Reactive Oxygen Species |
| 02/10/2011 | US20110033531 Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof |
| 02/10/2011 | US20110033518 Peptides promoting lipid efflux via abca1 and activating a lipoprotein lipase |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033446 Treatment of HIV-1-infected individuals to reduce risk of coronary artery disease and suppress virus replication |
| 02/10/2011 | US20110033418 Treatment of diseases caused by viral infection |
| 02/10/2011 | US20110033414 Cardiovascular therapy composition including transfer factor and therapeutic methods including use of the composition |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | CA2770405A1 Sulfone derivative |
| 02/10/2011 | CA2770404A1 Amide derivative |
| 02/10/2011 | CA2769883A1 Use of melanocortins to treat dyslipidemia |
| 02/10/2011 | CA2769665A1 Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins) |
| 02/10/2011 | CA2769615A1 Use of cajeput and pimenta racemosa extract for treating parasitic infestation of fish |
| 02/10/2011 | CA2768999A1 Compositions and methods for treating gaucher disease |
| 02/10/2011 | CA2768041A1 Prodrugs of desazadesferrothiocin polyether analogues as metal chelation agents |
| 02/09/2011 | EP2281828A2 Compositions comprising modified erythropoietin |
| 02/09/2011 | EP2281823A2 Anti-inflammatory and analgesic piperidine derivatives |
| 02/09/2011 | EP2281818A1 Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient |
| 02/09/2011 | EP2281817A1 Substituted carbinol compound having cyclic linker |
| 02/09/2011 | EP2281816A1 New crystalline pyrithione/zinc oxide complex and physiologic/antibiotic active composite containing the same |
| 02/09/2011 | EP2281578A2 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 02/09/2011 | EP2281568A2 Uses of soluble CTLA4 mutant molecules |
| 02/09/2011 | EP2281567A1 Inhibitor for blood phosphorus level elevation |
| 02/09/2011 | EP2281561A2 Use of LCK inhibitors for treatment of immunologic diseases |
| 02/09/2011 | EP2281560A1 Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucomatous optic neuropathy |
| 02/09/2011 | EP2280983A2 C-aryl glycoside compounds for the treatment of diabetes and obesity |
| 02/09/2011 | EP2280966A1 Azabicyclo [3.2.1]octyl derivatives as 11 beta-hsd1 modulators |
| 02/09/2011 | EP2280955A2 Crystalline form of 6-ý(4s)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl¨pyridazin-3-amine |
| 02/09/2011 | EP2280952A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators |
| 02/09/2011 | EP2280935A1 4-trimethylammonio-butyrates as cpt2 inhibitors |
| 02/09/2011 | EP2280706A1 Lipoprotein lipase-activating compositions comprising benzene derivates |
| 02/09/2011 | EP2051722B1 Method for treating diabetic vascular complications |
| 02/09/2011 | EP1947111B1 Mucin glycoprotein and use thereof |
| 02/09/2011 | EP1943251B1 A1 adenosine receptor agonists |
| 02/09/2011 | EP1924579B1 Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives |
| 02/09/2011 | EP1874140B1 Peptides having a health benefit and compositions comprising them |
| 02/09/2011 | EP1819227B1 Pharmaceutical formulation of decitabine |
| 02/09/2011 | EP1654224B1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/09/2011 | EP1451192B1 Novel crystalline compound |
| 02/09/2011 | EP1381385B1 Insulin preparations, which do not contain any zinc or only a small quantity of zinc and which have an improved stability |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | CN101970639A Microorganism producing cyclic compound |
| 02/09/2011 | CN101970458A Novel gamma-secretase inhibitor |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970441A Imidazo [1,2-b] pyridazine compounds as modulators of liver x receptors |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970402A Pyrrolidine derivatives |
| 02/09/2011 | CN101969979A Apoaequorin-containing compositions and methods of using same |
| 02/09/2011 | CN101969958A Vitamin d compositions and method of administration to a human being |
| 02/09/2011 | CN101969946A Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid |
| 02/09/2011 | CN101969932A Capsule formulation |
| 02/09/2011 | CN101967205A Beta-dextriferron composite and preparation method thereof |
| 02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
| 02/09/2011 | CN101967159A Amino acid Schiff base ligand-containing vanadium oxide compound |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967143A Ligands for G-protein coupled receptors |
| 02/09/2011 | CN101967123A 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof |
| 02/09/2011 | CN101967117A Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
| 02/09/2011 | CN101967113A 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof |
| 02/09/2011 | CN101967094A Phenylacetyl quinic acid of witlooves and ester compound thereof |
| 02/09/2011 | CN101966309A Traditional Chinese medicine for treating diabetes limb necrosis |
| 02/09/2011 | CN101966299A Medicament for treating wind-caused dizziness |
| 02/09/2011 | CN101966296A Traditional Chinese medicine for treating diabetic constipation |
| 02/09/2011 | CN101966294A External traditional Chinese medicine for slimming |
| 02/09/2011 | CN101966292A Sugarless Chinese medicinal oral liquid and preparation method thereof |
| 02/09/2011 | CN101966286A Traditional Chinese medicine for treating diabetic eye diseases |
| 02/09/2011 | CN101966281A Traditional Chinese medicine for treating diabetic stomach paralysis |
| 02/09/2011 | CN101966280A Traditional Chinese medicine for treating diabetes mellitus and gout |
| 02/09/2011 | CN101966279A Traditional Chinese medicine for treating diabetic gout |
| 02/09/2011 | CN101966268A Traditional Chinese medicinal preparation for improving pig cutability |
| 02/09/2011 | CN101966260A Chinese medicinal capsules for treating limb numbness and pain of diabetic concurrent peripheral neuropathy |
| 02/09/2011 | CN101966259A Traditional Chinese medicine for treating diabetic pruritus |
| 02/09/2011 | CN101966258A Traditional Chinese medicine for treating diabetic retinopathy |
| 02/09/2011 | CN101966253A Tao hong si wu granule and preparation method thereof |
| 02/09/2011 | CN101966239A Chinese medicinal composition for preventing and treating cardiac cerebral and vascular diseases and preparation method thereof |
| 02/09/2011 | CN101966228A Mangnolia officinalis alkaloid, extraction method and applications thereof |
| 02/09/2011 | CN101966221A Application of prickly pear in preparation of medicaments or health-care products |
| 02/09/2011 | CN101966205A Auxiliary material-free superfine powder tablets and preparation method thereof |
| 02/09/2011 | CN101966202A Fishy smell-free multi-dimensional fish oil emulsion composition and preparation method thereof |
| 02/09/2011 | CN101966184A Vitamin B complex injection for treating porcine indigestion and preparation method |
| 02/09/2011 | CN101966175A Application of dehydroabietic silybin in preparing glycosidase inhibitors |
| 02/09/2011 | CN101966174A Pharmaceutical application of p-bromocinnamoyl silybin to preparing glycosidase inhibitors |
| 02/09/2011 | CN101966173A Medicinal use of dinitrobenzoylsilybin for preparing glycosidase inhibitor |
| 02/09/2011 | CN101966171A Hydrosoluble reduced enzyme Q10 composition and preparation method thereof |
| 02/09/2011 | CN101966162A Insulin buccal tablets and preparation method thereof |
| 02/09/2011 | CN101966148A Injection composition comprising coenzyme Q10 and preparation method thereof |
| 02/09/2011 | CN101966140A Method for preparing fishy smell removed submicron pearl powder with regular geometric shape |
| 02/09/2011 | CN101647991B Compound astragalus root fat-reducing and body-building granule |
| 02/09/2011 | CN101647837B Production technique for deep processing of active ginseng |
| 02/09/2011 | CN101574334B Method for preparing calcium gluconate preparation |
| 02/09/2011 | CN101519458B Method for extracting tea polysaccharides and tea polyphenol from coarse old green tea |
| 02/09/2011 | CN101518591B Traditional Chinese medicine for treating diabetic constipation |
| 02/09/2011 | CN101486688B DPP-IV inhibitor with sulfonyl amine acyl alkyl piperazine structure |
| 02/09/2011 | CN101485787B Chinese medicament preparation for treating obesity |
| 02/09/2011 | CN101433534B Use of resveratrol dimer for preparing medicament for reducing blood sugar |
| 02/09/2011 | CN101384595B Salt of CD 80 antagonist |
| 02/09/2011 | CN101348433B 4-alkoxy-coumarin fatty acid ester, synthetic method and use |
| 02/09/2011 | CN101341915B Multifunctional health tea |
| 02/09/2011 | CN101244988B Method for extracting paclitaxel extract, extracting and purifying sequoyitol |
| 02/09/2011 | CN101244987B Method for extracting and purifying sequoyitol by using solvent circulation reflux |